Welcome to the ATTD 2023 Interactive Program
Session Description:
This symposium will discuss Tempo™, a Personalized Diabetes Management System and Lyumjev®, a fast-acting mealtime insulin from Eli Lilly.
The Tempo system helps automate insulin dose tracking for people managing their diabetes.
Faculty will discuss how accurately and automatically tracking insulin doses with the Tempo system can help simplify diabetes management for people with diabetes while improving collaboration and enabling more meaningful conversations with their healthcare professional.
Lyumjev is a formulation of insulin lispro indicated for the treatment of diabetes mellitus in adults, adolescents and children aged 1 year and above.
Faculty will discuss the clinical profile of Lyumjev and how it:
•Has the fastest insulin absorption and a shorter duration of exposure when compared to Humalog®
•Helps reduce post-prandial glucose without increased risk of hypoglycaemia
•Significantly outperformed Humalog when dosed at the start of a meal
This program is for all healthcare professionals treating people with diabetes on multiple daily injections of mealtime insulin.